CN117202795A - 婴儿配方奶粉 - Google Patents
婴儿配方奶粉 Download PDFInfo
- Publication number
- CN117202795A CN117202795A CN202280026898.2A CN202280026898A CN117202795A CN 117202795 A CN117202795 A CN 117202795A CN 202280026898 A CN202280026898 A CN 202280026898A CN 117202795 A CN117202795 A CN 117202795A
- Authority
- CN
- China
- Prior art keywords
- infant formula
- formula
- formulation
- infant
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 118
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 30
- 108010014251 Muramidase Proteins 0.000 claims abstract description 30
- 102000016943 Muramidase Human genes 0.000 claims abstract description 30
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 30
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 30
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 30
- 229960000274 lysozyme Drugs 0.000 claims abstract description 28
- 239000004325 lysozyme Substances 0.000 claims abstract description 28
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 20
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 20
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 20
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 20
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 20
- 229910052751 metal Inorganic materials 0.000 claims abstract description 16
- 239000002184 metal Substances 0.000 claims abstract description 16
- 235000018102 proteins Nutrition 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 12
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 12
- 239000003925 fat Substances 0.000 claims abstract description 12
- 235000019197 fats Nutrition 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 11
- 150000002739 metals Chemical class 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 10
- 229930003231 vitamin Natural products 0.000 claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 claims abstract description 10
- 239000011782 vitamin Substances 0.000 claims abstract description 10
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 9
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 9
- 150000002367 halogens Chemical class 0.000 claims abstract description 9
- 239000011574 phosphorus Substances 0.000 claims abstract description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 9
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 9
- 239000011669 selenium Substances 0.000 claims abstract description 9
- 150000003856 quaternary ammonium compounds Chemical class 0.000 claims abstract description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims abstract description 7
- 229960004203 carnitine Drugs 0.000 claims abstract description 7
- 229960001231 choline Drugs 0.000 claims abstract description 7
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000006041 probiotic Substances 0.000 claims abstract description 7
- 235000018291 probiotics Nutrition 0.000 claims abstract description 7
- 229960003080 taurine Drugs 0.000 claims abstract description 7
- 238000009472 formulation Methods 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- -1 choline or carnitine Chemical class 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 2
- 235000020256 human milk Nutrition 0.000 abstract description 11
- 229940099472 immunoglobulin a Drugs 0.000 abstract description 11
- 229940027941 immunoglobulin g Drugs 0.000 abstract description 10
- 235000001014 amino acid Nutrition 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 229940072221 immunoglobulins Drugs 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 description 4
- 230000005965 immune activity Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 229960004488 linolenic acid Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 210000004251 human milk Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 102000003839 Human Proteins Human genes 0.000 description 2
- 108090000144 Human Proteins Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000005007 innate immune system Anatomy 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 229940051921 muramidase Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046001 vitamin b complex Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 208000024818 Nipple disease Diseases 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 102000025171 antigen binding proteins Human genes 0.000 description 1
- 108091000831 antigen binding proteins Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 108010060371 endo-N-acetylmuramidase Proteins 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical group 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Liquid Crystal Substances (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
一种婴儿配方奶粉,其包含人母乳的特定免疫活性成分,即溶菌酶和/或至少一种免疫球蛋白如免疫球蛋白A和/或免疫球蛋白G。婴儿配方还包含乳铁蛋白。溶菌酶的浓度重量百分比为组合物的约0.1‑1.0%,免疫球蛋白的浓度重量百分比为组合物的约0.1‑1.5%,乳铁蛋白的浓度重量百分比为约0.1‑2.0%。婴儿配方进一步包含一种或多种维生素、脂肪、蛋白质、碳水化合物、元素如一种或多种金属、卤素、磷和硒、一种或多种季铵化合物如胆碱和/或肉碱、一种或多种氨基酸如牛磺酸和/或益生元和/或益生菌。
Description
技术领域
本发明涉及一种婴儿配方奶粉配方,更具体地说,
本发明涉及一种包含人类母乳中特殊免疫活性成分的婴儿配方奶粉配方。
背景技术
婴儿配方奶粉通常被当作人类母乳的替代品或补充品。一般而言,婴儿配方奶粉包含蛋白质、脂肪、碳水化合物、
维生素、矿物质和其他分子成分,这些成分与在母乳中发现的成分至少非常接近,并且他们的含量能为婴儿提供适宜的营养。
当婴儿无法“衔住”乳房或缺乏强烈的吸吮反射,或母亲出现乳房疾病,如乳腺炎或乳头皲裂,导致母亲无法母乳喂养时,
婴儿配方奶粉可能就很有用。
当母乳喂养较少或出现间断(如母亲上班),或母亲生病或营养不良时,可能就需要使用补充品,这可能会对母乳的产量和质量造成不良影响。
即使不存在任何母乳喂养问题,婴儿配方奶粉也是母乳喂养的一种方便营养的替代品。
婴儿配方奶粉可以被制造成可加水重新调配的干燥的颗粒状或粉末状形式,也可以被制造成即食的液态形式。
发明内容
本发明广泛涉及一种包含人类母乳中特殊免疫活性成分的婴儿配方奶粉,现有技术的婴儿配方奶粉中通常不包含这些成分。本婴儿配方奶粉以一种非常广泛的形式,包含溶菌酶或至少一种免疫球蛋白,如免疫球蛋白A或免疫球蛋白G。
优选地,所述婴儿配方奶粉还包含了乳铁蛋白。
一方面,本发明提供了一种用于婴儿配方奶粉的配方,前述配方包含溶菌酶或一种免疫球蛋白。
在一个实施例中,所述配方包含溶菌酶和/或一种选自IgA(免疫球蛋白A)和IgG(免疫球蛋白G)的免疫球蛋白。
在一个实施例中,溶菌酶的含量在配方的重量中所占百分比约为0.1%至1.0%,优选地在配方的重量中所占百分比约为0.2%至0.8%,更优选地在配方的重量中所占百分比约为0.4%至0.7%,
甚至更优选地在配方的重量中所占百分比约为0.52%。
在一个实施例中,免疫球蛋白在配方的重量中所占百分比约为0.1%至1.5%,
优选地在配方的重量中所占百分比约为0.3%至1.2%,更优选地在组成的重量中所占百分比约为0.6%至1.0%,
甚至更优选地在配方的重量中所占百分比约为0.85%。
在一个特定实施例中,配方中还包含了乳铁蛋白。在一个实施例中,
乳铁蛋白的含量在配方的重量中所占百分比约为0.1%至2.0%。
适宜地,所述配方中进一步包含了一种或多种维生素、脂肪、蛋白质、碳水化合物,以及元素,如一种或多种金属、卤素、磷和硒、一种或多种季铵盐化合物(如胆碱和/或肉碱)、一种或多种氨基酸(如牛磺酸)和/或益生元。
在一个实施例中,所述组合基本如表1所列。
适宜地,所述配方采用干燥的粉末或颗粒形式,能用水重新调配成适合喂养婴儿的婴儿配方奶粉。
另一方面,本发明提供了一种包含
溶菌酶和/或免疫球蛋白婴儿配方奶粉。
适宜地,所述配方奶粉采用一种适合喂养婴儿的液态形式。
在一个实施例中,所述幼儿配方奶粉包含溶菌酶和/或至少一种选自IgA和IgG的免疫球蛋白。
在一个实施例中,溶菌酶在所述婴儿配方奶粉中的含量约为0.01至0.15克/100毫升,
0.03to0.12克/100毫升,约0.05to0.10克/100毫升,或更优选地约0.07克/100毫升。
在一个实施例中,免疫球蛋白在所述婴儿配方奶粉中的含量约为0.01至0.25克/100毫升,大约0.02至18克/100毫升,约为0.04至15克/100毫升,
或优选地为0.11克/100毫升。
在一个特定实施例中,所述婴儿配方奶粉还包含了乳铁蛋白。
在一个实施例中,乳铁蛋白的含量约为0.03至0.30克/100毫升,优选地约为0.18克/100毫升。
适宜地,所述婴儿配方奶粉中还包含了一种或多种维生素、脂肪、蛋白质、碳水化合物,以及元素如一种或一种以上金属、卤素、磷和硒、一种或一种以上季铵盐化合物。
如胆碱和/或肉碱、一种或一种以上氨基酸(如牛磺酸)和/或益生元。在一个实施例中,所述婴儿配方奶粉基本如表1所列。
再一方面,本发明提供了一种婴儿配方奶粉的制备方法,前述方法包括将上述第一方面提到的配方与水混合从而制备婴儿配方奶粉的步骤。
这个方面也提供利用这个方面的方法生产的婴儿配方奶粉。
在另外一个方面,本发明提供了一种喂养婴儿的方法,前述方法包括向婴儿喂养第二方面所提到的婴儿配方奶粉或
利用第三方面提到的方法生产的婴儿配方奶粉的步骤。
具体实施方式
本发明是至少部分基于在婴儿配方奶粉中使用溶菌酶和免疫球蛋白(如IgA)从而提供一种包含人类母乳成分的婴儿配方奶粉,
提高婴儿配方奶粉的营养价值和免疫力价值。优选地,本婴儿配方奶粉还包含乳铁蛋白。这样就提供了营养丰富、安全、方便易用的配方以及婴儿奶粉,提供了额外的人类蛋白如溶菌酶和免疫球蛋白,使其更类似或接近于人类母乳
和/或提供了更强的免疫活性。
在本说明书全文中,除非另有说明,“包含”是包容性而非排他性的含义,
因此所描述的一个整数或一组整数可以包含一个或一个以上其他未描述的整数或一组整数。
还应理解的是,英语中的不定冠词“a(一个)”和“an(一个)”不应理解为单数不定冠词,也不应理解为不包含一个或
一个以上不定冠词所指代的主体。例如,“a(一种)”蛋白质包含一种蛋白质、一种或一种以上的蛋白质以及多种蛋白质。
在本说明书中使用的术语“约”代表所述数值可能存在变动或偏差。所述变动或
偏差应低于所述值的±10%、±9%、±8%、±7%、±6%、±5%、±4%、±3%、±2%、或±1%。
在本说明书所使用的术语“蛋白质”,指的是一种氨基酸聚合物,包含天然或非天然氨基酸、D型或L型氨基酸。蛋白质可以是天然或重组形式,还可以进一步包含其他部分,例如碳水化合物(如糖蛋白)、脂类(如脂蛋白、糖脂蛋白)和/或核酸(如核糖核蛋白)。
在本说明书所使用的术语“脂肪”包括脂质、蜡、脂肪酸、甘油酯和固醇,包括其盐类,但不限于此。脂肪通常由一个或多个烃(即脂肪族)链和/或环配方,可以是饱和、单不饱和、双不饱和或多不饱和脂肪。而不饱和脂肪酸链可以是顺式或反式。
脂肪酸脂肪链包含约5到22个碳原子。
在本说明书所使用的术语“碳水化合物”指由碳原子、氧原子和氢原子配方的分子,包括但不限于糖类(如单糖、寡糖、多糖),如糖、淀粉和纤维素。
一方面,本发明提供了一种用于婴儿配方奶粉的配方,前述配方包含溶菌酶和/或一种免疫球蛋白。
“溶菌酶”是一种蛋白质,也被称为胞壁质酶(muramidase)或N-乙酰胞壁质聚糖水解酶,它是一种抗菌酶,是先天免疫系统的一部分。溶菌酶是一种糖苷水解酶,
可催化肽聚糖中N-乙酰木酰胺酸和N-乙酰-D-葡糖胺残基之间的β(1→4)连接的水解,而肽聚糖是革兰氏阳性细菌细胞壁的主要成分。这种水解反过来会损害细菌细胞壁的完整性,
导致细菌溶解。溶菌酶通常存在于母乳中,是向婴儿“传送”先天免疫力的来源。
虽然希望不受限于理论,但仍然建议在本说明书公开的配方和婴儿配方奶粉中添加溶菌酶,
至少可以部分增强或改善婴儿配方奶粉的免疫活性。
在一个实施例中,溶菌酶的含量在配方的重量中所占百分比约为0.1%至1.0%,优选地约为0.2%至0.8%,更优选地约为0.4%至0.7%,
或约为0.52%。
溶菌酶可从鸡蛋白、菜花、牛乳、蜂蜜、人血清或牛奶、水果、蔬菜、豆腐、腐乳、海产品、肉类、马铃薯和/或牛蒡中提取,也可以用生物合成的方式生产,如重组蛋白。
如前文所述,所述配方中还包含一种免疫球蛋白。
如本说明书中所使用,“免疫球蛋白”是一种由哺乳动物免疫球蛋白基因复合物编码的抗原结合蛋白(通常称为"抗体")或其片段。
免疫球蛋白通常包括IgM、IgG、IgA、IgD和IgE等同型。同型还可以分为IgG1、IgG2、IgG3和IgG4等亚型,它们的区别在于恒定区,特别是铰链和上部的CH2结构域。免疫球蛋白是原生或重组形式的多克隆或单克隆和/或包括抗体片段,如scFv、Fc、Fab和/或F(ab')2片段。
合成抗体也被纳入考虑范围,如二抗体、三抗体和/或其他多特异性合成抗体。
免疫球蛋白,尤其是IgA,通常存在于人类母乳中,从而向婴儿提供源自母体的抗菌抗体保护。
虽然希望不受限于理论,但仍然建议在本文所公开的配方和婴儿配方奶粉中添加免疫球蛋白(例如IgA和/或IgG),
至少可以部分增强或改善婴儿配方奶粉的免疫活性。
在一个实施例中,免疫球蛋白的含量在配方的重量中所占百分比约为0.1%到1.5%,优选地,占配方重量的百分比约为0.3%到1.2%,更
优选地,占配方重量的百分比约为0.6%到1.0%,或占配方重量的百分比约为0.85%。
适宜地,配方包含了一种选自IgA和IgG的免疫球蛋白。
IgG可以从自然中获取,例如牛乳中存在的IgG。
IgA可以从商业来源中或通过生物合成(如重组蛋白)获取。优选地,IgA是人类IgA。
在一个特定实施例中,所述配方中还包含了乳铁蛋白。这是一种分子量约为80kD的球状糖蛋白(“乳转铁蛋白”),
它能结合铁离子并将它转移到细胞中,能控制血液和外部分泌物中游离铁的含量。
它存在于人类和其他哺乳动物的乳汁、血浆和中性粒细胞中,基本是哺乳动物所有的外分泌物(如唾液、胆汁、眼泪和胰腺分泌物)中的主要蛋白质之一。乳铁蛋白还具有抗菌活性(如抗细菌和真菌),是先天免疫系统的一部分,特别是粘膜部位。
在一个实施例中,乳铁蛋白在配方中所占的重量百分比约为0.1%到2.0%。
优选地,乳铁蛋白可以来源于牛或人类,也可以来源于商业途径如FreedomFoodsGroupLimited(自由食品集团有限公司)。
所述配方通常还包含一些其他的蛋白质,例如白蛋白,
包含正乳白蛋白和血清白蛋白,但不限于此。
适宜地,所述配方还包含了一种或一种以上维生素、脂肪、碳水化合物,以及元素如一种或一种以上的金属、卤素、磷和/或硒、季铵化合物、氨基酸或益生元、或益生菌。
维生素可以包合复合维生素B,如维生素B6、维生素B12、烟酸、硫胺素、叶酸、生物素、核黄素和/或泛酸、维生素C、维生素D、维生素K和/或维生素E。
脂肪可以包含亚麻酸、α-亚麻酸、花生四烯酸、二十二碳六烯酸(DHA)、欧米茄3和/或欧米茄6脂肪酸等脂肪酸。所述配方还可以包含一种或多种元素,如金属。
金属可以是离子或原子金属形式。金属可以包括过渡金属、
碱金属和/或碱土金属。金属的非限制性实例包括钠、钙、铬、硼、钾、铁、铜、锰、镁、钼和/或锌。
所述配方还包含一种或一种以上的元素(如硒和磷)和/或卤素,如氯(如氯离子),
和/或碘,但不限于此。
所述配方还可以包含一种或一种以上季铵盐化合物,如胆碱和/或肉碱,以及一种或一种以上氨基酸,如牛磺酸。
所述配方还可以包含碳水化合物,如肌醇、
低聚半乳糖(GOS)益生元和低聚果糖(FOS)益生元,但不限于此,还可以包含益生菌。
表1列出了所述配方的一个特定实施例,包含了配方中每一种成分的特定含量和偏差范围。
从上述内容应该可以理解,本说明书公开的配方适合用作婴儿配方奶粉。
在一个实施例中,所述配方以干燥或脱水的粉末或颗粒形式提供。制备干燥或脱水的粉末状或颗粒状婴儿配方奶粉的方法在本领域是众所周知的,
通常包括将各种成分(如本说明书特别参照表1公开的)
混合成水基浆料,然后干燥或脱水浆料以生产粉末状或颗粒状婴儿配方奶粉。这种工艺通常还包括在浆料干燥或脱水之前的净化和均质化步骤。
生产过程中的一个特别重要的考虑因素是向婴儿喂食所述配方和配方奶粉是安全的。
适宜地,将干燥或脱水的粉末状或颗粒状配方与水组合后调制成婴儿配方奶粉。
优选地,所述配方与水组合时,比例应为约13克奶粉加100毫升水。但是,应当理解的是这个比例可以根据婴儿的营养需求随时调整。
在一个替代实施例中,所述婴儿配方奶粉是一种
无需加水调制的预制液态婴儿配方奶粉。
在婴儿配方奶粉的一个实施例中,溶菌酶在婴儿配方奶粉中的含量约为0.01至0.15克/100毫升、0.03至0.12克/100毫升、约为婴儿配方奶粉0.05至0.10克/100毫升,或优选地在婴儿奶粉中的含量约0.07克/100毫升。
在一个实施例中,免疫球蛋白(如IgA或IgG)在婴儿配方奶粉中的含量约为0.01至0.25克/100毫升,
约为0.02至0.18克/100毫升,约为0.04至0.15克/100毫升,或优选地,约为0.11克/100毫升。
本婴儿配方奶粉还可以包含乳铁蛋白。
在一个实施例中,乳铁蛋白在本婴儿奶粉中的含量约为0.03到0.30克/100毫升,或优选地,约为0.18克/100毫升。
一般情况下,婴儿配方奶粉还可以包含其他蛋白质,如白蛋白,包含正乳白蛋白和血清白蛋白,但不限于此。
适当地,婴儿配方奶粉还包括一种或一种以上维生素、脂肪、碳水化合物以及一种或一种以上元素如金属、卤素、磷
和/或硒、一种或一种以上季铵盐化合物、一种或一种以上氨基酸和/或一种或一种以上益生元和/或益生菌。
维生素可以包含复合维生素B,如维生素B6、维生素B12、烟酸、硫胺素、叶酸、生物素、核黄素和/或泛酸、维生素C、维生素D、维生素K和/或维生素E,但不限于此。
脂肪可以包含亚麻酸、α-亚麻酸、花生四烯酸、二十二碳六烯酸(DHA)、欧米茄3和/或欧米茄6脂肪酸等脂肪酸。金属可以是离子或原子金属形式。金属可包括过渡金属、碱金属和/或碱土金属。金属的非限制性实例包括钠、铬、硼、钙、钾、铁、铜、锰、
镁、钼和/或锌。
婴儿配方奶粉还可以包含一种或一种以上元素,如硒和磷,和/或卤素,如氯(如氯离子)和/或碘,但不限于此。
婴儿配方奶粉可进一步包含一种或一种以上季铵盐化合物,
如胆碱和/或肉碱。婴儿配方奶粉可进一步包含一种或一种以上氨基酸,如牛磺酸。
本婴儿配方奶粉还包含碳水化合物,如肌醇、低聚半乳糖(GOS)益生元和低聚果糖(FOS)益生元,但不限于此,还可以包含益生菌。
表1列出了本婴儿配方奶粉的一个特定实施方案,其中包括婴儿配方奶粉中每种组分的特定比例。
在另一个方面,本发明还提供了一种喂养婴儿的方法,前述方法包括向婴儿喂养上述第二点描述的婴儿配方奶粉或按照上述第三点的方法生产的婴儿
配方奶粉的步骤。
一般而言,婴儿可以是新生儿,也可以是三(3)岁以下的婴儿,但婴儿的年龄最好不超过12-18个月。因此,虽然婴儿配方奶粉是特别为婴儿生产的,但它也可以适用于幼儿或“学部儿童”。
给婴儿喂食的婴儿配方奶粉的量或体积,至少部分取决于婴幼儿的年龄,以及婴儿配方奶粉是作为其他营养的"补充"(通常是幼儿的情况时),还是基本上是唯一的营养来源。举例来说,从出生五天到三个月,一个足月健康的婴儿每天每公斤体重大约需要150毫升配方奶粉。
例如,体重为3公斤的婴儿每天需要450毫升配方奶粉。
配方奶粉一般是通过带有奶嘴的奶瓶喂给婴幼儿的,
婴幼儿的吸吮动作有助于婴儿配方奶粉的摄入。
在某些情况下,如果婴儿有吸吮困难、胃肠道缺陷、呼吸系统问题或其他健康问题,
婴儿配方奶粉可以通过经口直接插入胃部的喂食管向婴儿喂食。
从上文可以看出,本发明提供了一种营养丰富、安全易用的配方和婴儿配方奶粉,它提供了额外的人类蛋白质,
如溶菌酶和免疫球蛋白,从而更类似或接近人类母乳,并至少部分提高了婴儿配方奶粉的免疫活性。
因此可以理解本文中披露的婴儿配方奶粉和制备方法尤其适合人类婴儿,
尽管本发明也可以用于喂养其他哺乳动物,尤其是那些营养需求与人类相似的灵长类动物的婴儿。
[表1]
在本说明书中的全文中,其目的是描述本发明的优选实施例,但不限制本发明于任何一个实施例或特定的特征集合。因此,本领域技术人员可以理解,根据本发明的公开内容,
在不偏离本发明范围的情况下,可以对示例的具体实施例进行各种修改和变更。
本文提及的所有计算机程序、算法、专利和科学文献均以引用方式并入本文。
Claims (23)
1.一种用作婴儿配方奶粉的配方,前述配方包含溶菌酶或免疫球蛋白。
2.如权利要求1所述的配方,其中包含溶菌酶或一种选自IgA和IgG的免疫球蛋白。
3.如权利要求1的所述配方,其中包含溶菌酶和一种选自IgA和IgG的免疫球蛋白。
4.如前述任一权利要求所述的配方,其中溶菌酶的含量占配方的重量百分比约0.1%至1.0%,优选约占0.2%至0.8%,更优选约占0.4%至0.7%,或约占配方总重量的0.52%。
5.如前述任一权利要求所述的配方,其中免疫球蛋白的含量占配方的重量百分比约0.1%至1.5%,优选约占0.3%至1.2%,更优选约占0.6%至1.0%,或约占配方总重量的0.85%。
6.如前述任一权利要求所述的配方,其中的配方中进一步包含了乳铁蛋白。
7.如权利要求6所述的配方,其中乳铁蛋白占配方总重量的百分比为0.1%至2.0%,优选占配方总重量的百分比为1.37%。
8.如前述任一权利要求所述的配方,进一步包含了一种或多种维生素、脂肪、蛋白质、碳水化合物以及元素,如一种或多种金属、卤素、磷和硒,一种或多种季铵盐化合物,如胆碱或肉碱,一种或多种氨基酸,如牛磺酸或益生元或益生菌。
9.如前述任一权利要求所述的配方,基本如表1所列。
10.如前述任一权利要求所述的配方,采用干燥的粉末状或颗粒状形式,可加水调整成婴儿配方奶粉。
11.一种包含溶菌酶和/或免疫球蛋白的婴儿配方奶粉。
12.如权利要求11所述的婴儿配方奶粉,包含溶菌酶和或至少一种选择IgA和IgG的免疫球蛋白。
13.如权利要求12所述的婴儿配方奶粉,包含溶菌酶和或至少一种选择IgA和IgG的免疫球蛋白。
14.如权利要求11-13中任一项所述的婴儿配方奶粉,其中溶菌酶的含量占配方的重量百分比约0.01克至0.15克/100毫升,0.03克至0.12克/100毫升,约0.05克至0.10克/100毫升,或优选地约0.07克/100毫升。
15.如权利要求11-14中任一项所述的婴儿配方奶粉,其中免疫球蛋白的含量占配方的重量百分比约0.01克至0.25克/100毫升,约0.02克至18克/100毫升,约0.04克至15克/100毫升或优选地0.11克/100毫升。
16.如权利要求11-15中任一项所述的婴儿配方奶粉,其中婴儿奶粉的配方进一步包含了乳铁蛋白。
17.如权利要求16中所述的婴儿配方奶粉,其中婴儿奶粉的配方进一步包含了乳铁蛋白。乳铁蛋白的浓度为约0.03至0.30g/100mL,或优选约0.18g/100mL所述婴儿配方奶粉。
18.如权利要求11-17中任一项所述的婴儿配方奶粉,其中进一步包含了维生素、脂肪、蛋白质、碳水化合物、以及元素,如一种或多种金属、卤素、磷和硒、一种或多种季铵盐化合物(如胆碱和/或肉碱)、一种或多种氨基酸(如牛磺酸)和/或一种或多种益生元和/或益生菌。
19.如权利要求11-18中任一项所述的婴儿配方奶粉,基本如表1所列。
20.一种制备婴儿配方奶粉的方法,前述方法包含将权利要求1-10任意所述的配方与水混合从而制备婴儿配方奶粉的步骤。
21.按照权利要求20制备的婴儿配方奶粉。
22.如权利要求21所述的婴儿配方奶粉,即权利要求11-19中任一项所述的婴儿配方奶粉。
23.一种喂养婴儿的方法,前述方法包含向婴儿喂养权利要求11-19、21或22中任意一项所述的婴儿配方奶粉的步骤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021900996A AU2021900996A0 (en) | 2021-04-06 | Infant formula | |
AU2021900996 | 2021-04-06 | ||
PCT/AU2022/050305 WO2022213149A1 (en) | 2021-04-06 | 2022-04-06 | Infant formula |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117202795A true CN117202795A (zh) | 2023-12-08 |
Family
ID=83544905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202280026898.2A Pending CN117202795A (zh) | 2021-04-06 | 2022-04-06 | 婴儿配方奶粉 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240196949A1 (zh) |
CN (1) | CN117202795A (zh) |
AU (1) | AU2022253776A1 (zh) |
GB (1) | GB2620887A (zh) |
WO (1) | WO2022213149A1 (zh) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1068871A1 (en) * | 1999-07-07 | 2001-01-17 | Jean-Paul Perraudin | Novel methods and medicament for treating infections diseases involving microbial biofilms |
WO2002064814A2 (en) * | 2001-02-14 | 2002-08-22 | Ventria Bioscience | Expression of human milk proteins in transgenic plants |
US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
JP2008512398A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳強化剤とその製法 |
CN101953403B (zh) * | 2010-09-25 | 2012-05-23 | 澳优乳业(中国)有限公司 | 添加分泌型免疫球蛋白a的婴幼儿配方奶粉及其制备方法 |
CN103155999B (zh) * | 2011-12-16 | 2015-08-26 | 光明乳业股份有限公司 | 一种营养素模块化婴幼儿奶粉及其原料组合物 |
CN105744845A (zh) * | 2013-11-29 | 2016-07-06 | 雀巢产品技术援助有限公司 | 具有磷脂的营养组合物 |
CN105638907A (zh) * | 2016-01-12 | 2016-06-08 | 东北农业大学 | 一种提高免疫力的婴儿配方奶粉 |
CN109069520A (zh) * | 2016-02-25 | 2018-12-21 | 应用生物实验室公司 | 保护空气传播的病原体和刺激物的组合物和方法 |
CN105746713A (zh) * | 2016-03-16 | 2016-07-13 | 东北农业大学 | 一种促进新生儿肠道黏膜免疫功能发育的婴儿配方奶粉 |
-
2022
- 2022-04-06 US US18/285,806 patent/US20240196949A1/en active Pending
- 2022-04-06 WO PCT/AU2022/050305 patent/WO2022213149A1/en active Application Filing
- 2022-04-06 AU AU2022253776A patent/AU2022253776A1/en active Pending
- 2022-04-06 CN CN202280026898.2A patent/CN117202795A/zh active Pending
- 2022-04-06 GB GB2316823.0A patent/GB2620887A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB2620887A (en) | 2024-01-24 |
US20240196949A1 (en) | 2024-06-20 |
WO2022213149A1 (en) | 2022-10-13 |
GB202316823D0 (en) | 2023-12-20 |
AU2022253776A1 (en) | 2023-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018101868A4 (en) | Milk Substitute Compositions | |
CN102458159B (zh) | 基于豌豆的蛋白质混合物以及其在适于肠道喂养的液体营养组合物中的用途 | |
CN102038041B (zh) | 一种婴幼儿矿物质配方奶粉 | |
RU2455857C2 (ru) | Питательная композиция | |
US9889162B2 (en) | Prophylactic use for prevention of infections | |
CN103392810A (zh) | 一种人乳化奶制品及其制备方法 | |
CN101427796A (zh) | 添加藻类二十二碳四烯酸适用于初生到6月的婴儿液态乳 | |
CN108013143A (zh) | 一种强化12~36个月婴幼儿胃肠道功能的配方奶粉 | |
CN112075504A (zh) | 增强免疫力的婴儿配方牛奶粉 | |
US20230218648A1 (en) | Use of human milk oligosaccharides in nutritional compositions for enhancing bone development and/or bone strength | |
Kim et al. | What nurses need to know regarding nutritional and immunobiological properties of human milk | |
WO2021068994A1 (zh) | 一种含燕窝酸和驼乳的奶粉 | |
CN101427791A (zh) | 添加藻类二十二碳四烯酸的适用于6-12月的婴儿液态乳 | |
CN112056403A (zh) | 一种新型儿童长高奶粉配方 | |
CN110637888A (zh) | 早产/低出生体重婴儿配方粉及其制备方法 | |
RU2703177C2 (ru) | Питание для младенцев с гидролизованным белком, ионным кальцием и пальмитиновой кислотой | |
Yu-Ying et al. | Effects of nutrient fortified complementary food supplements on anemia of infants and young children in poor rural of Gansu | |
CN117202795A (zh) | 婴儿配方奶粉 | |
TW201032734A (en) | Nutritional composition for infants | |
CN117481199A (zh) | 促进生长发育的早产/低出生体重婴儿食品及其制备方法与应用 | |
Francisquini et al. | How the heat treatment affects the constituents of infant formulas: a review | |
CN102405975B (zh) | 一种改善儿童厌食症的液态乳制品及其制备方法 | |
CN107529805A (zh) | 包含胆碱及其衍生物的组合物,其制备方法和用途 | |
Rashid et al. | Studies on the nutritional composition of goat (Beetal) colostrum and its mature milk | |
RU2703172C2 (ru) | Питание для младенцев с гидролизованным белком и пальмитиновой кислотой |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |